mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |